Queen City Angels
-
Queen City Angels’ chairman testifies before Congress on angel investing
Queen City Angels’ Chairman Tony Shipley testified before a House subcommittee last week on the […]
-
Streamline the Process for Consent Collection and Management
Join us on April 16th and hear executives from DocuSign and Velatura discuss how their partnership modernizes and facilitates the efficient and secure completion of the patient consent form.
-
Stroke diagnosis company IschemiaCare planning clinical study
A startup that’s developing a blood test to diagnose the cause of stroke is planning […]
-
Queen City Angels aims for new $6M fund
Queen City Angels, a frequent investor in early stage healthcare startups, is hoping to raise […]
-
Stroke diagnosis firm IschemiaCare closes $800K of $1.1M investment
A company that’s hoping to be the first to commercialize a blood test that can […]
-
Minimally Invasive Devices raises $1.5M, eyes new product launches
Surgical device maker Minimally Invasive Devices has raised more than $1.5 million in equity, according to a document filed with the Securities and Exchange Commission.
-
Ohio startup looks to commercialize blood test for stroke cause
Don’t accuse molecular diagnostics startup Ischemia Care of thinking small. The Oxford, Ohio-based company that was founded three years ago is hoping to be the first company to market with a blood test to diagnose the cause of stroke, the fourth-leading cause of death in the United States. And it’s hoping to do that within two years.
-
Blue Ash Therapeutics raises $2M-plus to push drug over finish line
Blue Ash Therapeutics has raised more than $2 million to help push its first and […]
-
Queen City Angels defy bad economy, invest in 8 health care companies
Queen City Angels invested in seven life sciences companies and one health information technology company […]
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
Columbus venture group Ohio TechAngel Funds raises $2.5M for third fund
Early stage venture group Ohio TechAngel Funds has raised $2.5 million for its third investment fund. Like the group’s previous funds, Ohio TechAngel Fund III will invest in Ohio-based technology companies in the life and physical sciences, and information technology industries.
-
BIOSTART, Queen City Angels team up to recruit life sciences investors
BIOSTART and Queen City Angels have formalized their long-standing relationship through a challenge: Jointly recruit 10 life sciences investors for the angel group within two years.
-
Neurostimulation device developer Neuros Medical Inc. wins $1.8 million from investors
Neuros Medical Inc., a start-up company that is developing a neurostimulation device to block chronic pain, has landed $1.8 million from several investors during its first round of venture financing. Neuros Medical will use the money to begin product development, hire a chief technology officer and complete clinical studies on its device that stimulates nerves to alleviate pain.
-
Entrepreneurs should have their credit cards ready
Tony Shipley of Queen City Angels says the old-school approach to starting a business is new again because of the dearth of private equity. Investors have become much more discerning — even among the companies they’ve invested in. “People casually thinking about entrepreneurship must be really committed to operating effectively and efficiently or else they’re better off keeping their day job,” Shipley said in an interview.
-
AssureRx hires new CEO, prepares for Series A fund-raise later this year
New chief executive James S. Burns is the former head of oncology and inflammatories drugmaker EntreMed. “This is a signal to our current and next investors that we’re ready to make the next step,” said Al Lucas, AssureRx’s vice president of sales and marketing.